1. Home
  2. XE vs RDY Comparison

XE vs RDY Comparison

Compare XE & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo X-Energy Inc. Class A Common Stock

XE

X-Energy Inc. Class A Common Stock

N/A

Current Price

$19.04

Market Cap

8.3B

Sector

Industrials

ML Signal

N/A

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$12.18

Market Cap

9.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XE
RDY
Founded
N/A
1984
Country
United States
India
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
9.9B
IPO Year
2026
2001

Fundamental Metrics

Financial Performance
Metric
XE
RDY
Price
$19.04
$12.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.90
AVG Volume (30 Days)
5.6M
2.9M
Earning Date
N/A
05-12-2026
Dividend Yield
N/A
0.52%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$7.72
Revenue Next Year
N/A
$3.50
P/E Ratio
N/A
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$13.29
$11.36
52 Week High
$23.99
$15.67

Technical Indicators

Market Signals
Indicator
XE
RDY
Relative Strength Index (RSI) 49.88 44.06
Support Level $13.56 $11.47
Resistance Level $20.18 $12.58
Average True Range (ATR) 2.01 0.20
MACD -0.14 0.06
Stochastic Oscillator 23.78 59.50

Price Performance

Historical Comparison
XE
RDY

About XE X-Energy Inc. Class A Common Stock

X-Energy Inc is a leading developer of advanced SMR and fuel technology for clean energy generation. It is seeking to redefine the nuclear energy industry through its flagship product, the Xe-100, an advanced small modular HTGR designed to generate up to 80 megawatts of electric power and/or up to 200 megawatts of thermal output, depending on the configuration. X-energy's simple and intrinsically safe advanced SMR designs, like the Xe-100, significantly expand the applications and markets for nuclear technology with enhanced safety, lower cost and faster construction timelines when compared with conventional nuclear energy sources and broader use cases when compared with other SMRs.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: